MORTON GROVE, Ill., Aug. 8, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY), a leading U.S. supplier of kefir and fermented probiotic products, is...
"With rising fire safety standards and the growing use of electric vehicles, demand for flame retardant chemicals is expanding across industries such as construction,...
"With rising fire safety standards and the growing use of electric vehicles, demand for flame retardant chemicals is expanding across industries such as construction,...
SAN FRANCISCO, Aug. 8, 2025 /PRNewswire/ -- According to a new in-depth market research study published by The Insight Partners, the global leather for automotive...
SAN FRANCISCO, Aug. 8, 2025 /PRNewswire/ -- According to a new in-depth market research study published by The Insight Partners, the global leather for automotive...
HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) today reported operational and financial results for the second quarter of 2025.
VANCOUVER, BC, Aug. 7, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...
VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...
The Group's advanced technologies and made in Italy quality ensure compliance to global standards, supply chain integrity and patient safety across the continent. In...
SINGAPORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three and six month periods ended June 30, 2025.
VANCOUVER, BC, Aug. 7, 2025 /CNW/ - (TSX: MER) (Nasdaq-Stockholm: MER) – Meren Energy Inc. ("Meren" or the "Company") will publish its financial and operating results, along with the...
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV.
TORONTO, Aug. 6, 2025 /CNW/ - Allied Gold Corporation (TSX: AAUC) (NYSE: AAUC) ("Allied" or the "Company") reports second quarter of 2025 production of...